RBP4 and metabolic dysfunction-associated steatotic liver disease: Cai et al. (2018) explored proteomic changes associated with nonalcoholic fatty liver disease, identifying 167 proteins and highlighting serum RBP4 and LGAL3BP as potential early diagnostic markers of alcoholic liver disease in postmenopausal women [26].